MedPath

developing a cbpt

Phase 3
Conditions
ADHD.
Attention-deficit hyperactivity disorder, combined type
Registration Number
IRCT20181104041548N1
Lead Sponsor
niversity of Tehran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
17
Inclusion Criteria

not receive cognitive-behavioral therapy (CBT)

Exclusion Criteria

inability to read and write

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptoms of ADHD. Timepoint: post test and 3 month follow up. Method of measurement: Child Symptom Inventory-4 (CSI-4).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath